The following data is part of a premarket notification filed by Oncospace, Inc. with the FDA for Oncospace.
Device ID | K202284 |
510k Number | K202284 |
Device Name: | Oncospace |
Classification | System, Planning, Radiation Therapy Treatment |
Applicant | Oncospace, Inc. 1812 Ashland Ave., Suite 100k Baltimore, MD 21205 |
Contact | Praveen Sinha |
Correspondent | Praveen Sinha Oncospace, Inc. 1812 Ashland Ave., Suite 100k Baltimore, MD 21205 |
Product Code | MUJ |
CFR Regulation Number | 892.5050 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2020-08-12 |
Decision Date | 2021-03-12 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00860004284901 | K202284 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ONCOSPACE 88367961 not registered Live/Pending |
Oncospace, Inc. 2019-04-02 |
ONCOSPACE 86875076 not registered Dead/Abandoned |
The Johns Hopkins University 2016-01-14 |
ONCOSPACE 85495019 not registered Dead/Abandoned |
The Johns Hopkins University 2011-12-14 |
ONCOSPACE 76324347 not registered Dead/Abandoned |
PHARMACIA ENTERPRISES S.A. 2001-10-11 |